LIGAND PHARMACEUTICALS INC's ticker is LGND and the CUSIP is 53220K504. A total of 243 filers reported holding LIGAND PHARMACEUTICALS INC in Q4 2020. The put-call ratio across all filers is 4.76 and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $275,000 | +32.2% | 4,567 | +57.9% | 0.00% | – |
| Q2 2023 | $208,000 | +2.5% | 2,892 | +4.4% | 0.00% | – |
| Q1 2023 | $203,000 | -20.7% | 2,770 | -6.6% | 0.00% | -100.0% |
| Q3 2022 | $256,000 | -3.4% | 2,967 | +0.1% | 0.00% | 0.0% |
| Q2 2022 | $265,000 | -20.4% | 2,964 | 0.0% | 0.00% | 0.0% |
| Q1 2022 | $333,000 | -29.0% | 2,964 | -2.5% | 0.00% | 0.0% |
| Q4 2021 | $469,000 | +11.9% | 3,041 | +0.6% | 0.00% | 0.0% |
| Q3 2021 | $419,000 | +6.3% | 3,023 | +0.7% | 0.00% | 0.0% |
| Q2 2021 | $394,000 | -14.0% | 3,003 | -0.3% | 0.00% | 0.0% |
| Q1 2021 | $458,000 | +48.7% | 3,012 | -2.4% | 0.00% | 0.0% |
| Q4 2020 | $308,000 | +6.2% | 3,085 | +1.4% | 0.00% | 0.0% |
| Q3 2020 | $290,000 | -15.5% | 3,043 | -9.7% | 0.00% | -50.0% |
| Q2 2020 | $343,000 | +26.1% | 3,369 | +240.3% | 0.00% | 0.0% |
| Q3 2018 | $272,000 | -55.6% | 990 | -77.9% | 0.00% | -60.0% |
| Q3 2017 | $613,000 | – | 4,474 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Knott David M Jr | 115,000 | $8,459 | 3.32% |
| VILLERE ST DENIS J & CO LLC | 480,807 | $35,368,162 | 2.57% |
| Chicago Capital, LLC | 449,508 | $33,065,822 | 1.64% |
| RICE HALL JAMES & ASSOCIATES, LLC | 288,345 | $21,210,681 | 1.20% |
| Smith, Graham & Co., Investment Advisors, LP | 65,163 | $4,793,390 | 0.58% |
| Stephens Investment Management Group LLC | 455,089 | $33,476,347 | 0.56% |
| CARDINAL CAPITAL MANAGEMENT LLC /CT | 201,993 | $14,858,605 | 0.53% |
| WOODSTOCK CORP | 52,604 | $3,869,550 | 0.49% |
| Court Place Advisors, LLC | 15,533 | $1,142,607 | 0.41% |
| Jackson Creek Investment Advisors LLC | 12,726 | $936 | 0.39% |